AJMC Staff

President Biden outlined new health initiatives in his first speech to a joint session of Congress; data show the disproportionate impact of air pollution on communities of color; COVID-19 case rates decline in half of US states.

Dostarlimab, for patients with recurrent or advanced deficient mismatch repair endometrial cancer, and a companion diagnostic, were recently approved by the FDA.

Besides demonstrating noninferiority in objective response rates, zanubrutinib also showed a statistically significant lower risk of atrial fibrillation or flutter compared with ibrutinib.

Patients with long COVID-19 at Veterans Health Administration facilities are being prescribed more addictive medications; indoor social distancing may provide a false sense of security; a drug for inflammatory bowel disease may blunt COVID-19 vaccine efficacy.

The United States will distribute 60 million doses of the AstraZeneca COVID-19 vaccine to other countries over the next several months; workplace safety rules on COVID-19 submitted by Labor Department for review; White House reportedly will not include measures targeting drug prices in antipoverty package.

Trial results showed an overall response rate of 48% and a complete response rate of 24%.

United States pledges medical aid to India amid COVID-19 surge; poll on attitude toward COVID-19 vaccines spotlight hesitancy among Republicans, non–health care essential workers; waiver fees for COVID-19-related treatments ending for insured patients of several health plans.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A study analyzes the effects of homelessness on childbirth; some states report drops in demand for COVID-19 vaccines; researchers examine long-term risks of severe COVID-19.

New reports show additional doses of Johnson & Johnson's (J&J) COVID-19 vaccine manufactured in Baltimore may be contaminated; legislation extends fentanyl's regulation as a Schedule 1 drug; COVID-19 cases and deaths increase in Texas.

Johnson & Johnson (J&J) will again administer its COVID-19 vaccine in the European Union; more women than men are being vaccinated against SARS-CoV-2; counterfeit Pfizer COVID-19 vaccines have been found in 2 countries.

All US adults are now eligible for COVID-19 vaccines; Biden administration considering policy to reduce the nicotine in all US-sold cigarettes to nonaddictive or minimally addictive levels; vaccines may ease lingering symptoms of COVID-19.

Nivolumab, marketed under the name Opdivo, led to a 29% reduced risk of death when combined with certain chemotherapies for gastric cancers.

Half of US adults have been administered 1 COVID-19 vaccine dose; researchers identify cause of clotting events associated with AstraZeneca vaccine; Anthony Fauci, MD, the chief medical advisor to the president, says he believes a decision on whether to resume the J&J vaccine will come by Friday.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Patients had atopic dermatitis for nearly 10 years before starting the biologic therapy.

If left untreated, patients with psoriatic arthritis (PsA) are at risk of irreversible joint damage, cardiovascular disease, and death. Some other conditions conflated with PsA include chronic eczema, seborrheic dermatitis, onychomycosis, lichen planus, and nodular prurigo.

Researchers did not find an association in people who had gout.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Study quantifies risk of blood clots in patients with COVID-19; Biden administration aims to reverse restrictions on fetal tissue research; Michigan hospitals struggle to care for COVID-19 cases.

A new study finds high rates of suicide among female nurses in the United States; President Joe Biden aims to undo Trump-era restrictions on abortion referrals; research indicates regular exercise may prevent severe COVID-19 outcomes.

While clinical trials have screened people with family risk of type 1 diabetes for many years, population-level screening for autoantibodies is not the norm.

Moderna announces upcoming trial of a vaccine candidate against flu; April 11-17 marks Black Maternal Health Week; the European Commission will not renew COVID-19 vaccine contracts with Johnson & Johnson and AstraZeneca when they expire next year.

A new study finds no link between the UK COVID-19 variant and more severe disease; study finds more than 1 in 10 US children with COVID-19 hospitalized; therapy setbacks in Huntington disease.

Adverse reactions to the Johnson & Johnson vaccine cause some states to pause distribution; the Biden administration proposes creation of a $6.5 billion medical research agency aiming to cure cancer and other diseases; Pfizer/BioNTech seeks expansion of its COVID-19 vaccine emergency use authorization in adolescents.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

The device, which highlights for gastroenterologists regions of the colon that have visual characteristics consistent with possible cancerous abnormalities, is already in use in Europe.

The study identifies the tumor-suppressing protein p53 as a working partner of “speckles,” nuclear structures that contain proteins and RNA involved in gene expression.